Literature DB >> 35459155

Correction: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival.

Sameer Ahmad Guru1,2, Mamta Pervin Sumi3, Rashid Mir4, Mirza Masroor Ali Beg5, Bidhan Chandra Koner6, Alpana Saxena7,8.   

Abstract

Entities:  

Year:  2022        PMID： 35459155      PMCID： PMC9027819          DOI： 10.1186/s12885-022-09568-3

Source DB:  PubMed          Journal:  BMC Cancer        ISSN： 1471-2407            Impact factor:   4.430


× No keyword cloud information.
Correction to: BMC Cancer 22, 1-15 (2022) https://doi.org/10.1186/s12885-022-09481-9 Following publication of the original article [1], the authors identified an error in the author name of Rashid Mir. The incorrect author name is: Abdul Rashid Mir The correct author name is: Rashid Mir The author group has been updated above and the original article [1] has been corrected.
  1 in total

1.  Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival.

Authors:  Sameer Ahmad Guru; Mamta Pervin Sumi; Rashid Mir; Mirza Masroor Ali Beg; Bidhan Chandra Koner; Alpana Saxena
Journal:  BMC Cancer       Date:  2022-04-14       Impact factor: 4.430
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.